Direct synthesis of bicyclo[1.1.1]pentane (BCP) boronates from carboxylic acids
Bicyclo[1.1.1]pentane (BCP) boronic esters are crucial intermediates for accessing BCP-containing drugs with improved pharmacokinetic profiles, yet their synthesis typically relies on pre-formed redox-active esters derived from carboxylic acids. Here we report a general, single-step method for the direct conversion of carboxylic acids into BCP boronic esters. Upon irradiation of carboxylic acids with [1.1.1]propellane and bis(pinacolato)diboron (B<sub>2</sub>pin<sub>2</sub>) in dimethyl sulfoxide (DMSO), BCP boronates are obtained in good yields, which are further enhanced by the addition of an iron catalyst. Mechanistic studies suggest that photolytic cleavage of a B<sub>2</sub>pin<sub>2</sub>-DMSO complex initiates decarboxylation via hydrogen atom transfer (HAT), while iron catalysis enables a parallel ligand-to-metal charge transfer (LMCT) pathway. This synergistic HAT/LMCT process displays broad substrate scope and remarkable functional group tolerance. Additionally, BCP analogs of two approved drugs, butenafine and buclizine, have been readily synthesized, underscoring the potential of this dual HAT/LMCT paradigm to reshape strategies in synthetic chemistry and drug discovery.
Authors
- Julian G. West (ORCID: https://orcid.org/0000-0002-3715-7883)
- Gang Wu (ORCID: https://orcid.org/0000-0001-6803-0853)
- Jess C Tang
- Yongchen Wang
Institutions
- The University of Texas Health Science Center (US)
- Rice University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1038/s41467-026-69851-w
- Primary Topic
- Radical Photochemical Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Research Corporation for Science Advancement
- Eli Lilly and Company
- Cancer Prevention and Research Institute of Texas
- University of Texas at Austin
- National Institutes of Health